Table 1

Characteristics of included studies

Study IDGPs (n*)Patient populationPreventionRiskConceptual methodological frameworkData collectionAnalysisCVD prevention topic area and scope
PrimarySecondaryAbsoluteRelative
Australia
Bonner et al, 201325 25GeneralNSPhenomenologicalSemistructured interviewFramework analysisRisk assessment
Bonner et al, 201427 25GeneralNSQualitativeSemistructured interviewFramework analysisRisk assessment
Bonner et al, 201533 25GeneralNSQualitativeSemistructured interviewFramework analysisRisk assessment
Liu et al, 201566 25IndigenousQualitativeSemistructured interviewsThematic analysisMedication
Pomeroy and Worsley, 200823 30GeneralNSNSMulti methodsSemistructured interviews and questionnaireConceptual analysisLifestyle change
Speechly et al, 201030 8Primary coronary heart diseaseQualitativeSemistructured interviewsThematic analysisLifestyle change/medication
Volker et al, 201726 11GeneralQualitativeSemistructured interviewsFramework analysisRisk assessment
Wan et al, 200867 22High-risk CV factorQualitativeFocus groups and semistructured interviewThematic analysisRisk assessment
Wan et al, 201028 22High-risk CV factorQualitativeFocus groupsThematic analysisRisk assessment
France
Lebeau et al 201640 125High-risk hypertensiveNSQualitativeOpen-ended questionnaireThematic analysisMedication
Guatemala
Montano et al, 200868 GeneralNSNSQualitativeFocus group discussions and in-depth interviewsThematic analysisLifestyle change
The Netherlands
Nielen et al, 201069 330GeneralNSQualitativeOpen-ended questionnaireThematic analysisLifestyle change
New Zealand
Doolan-Noble et al, 201231 29High CVD riskQualitativeFocus groupThematic analysisBarriers and facilitators
Sapre et al, 200970 20Primary myocardial infarctionQualitativeSemistructured interviewConceptual analysisMedication
Torley et al, 200571 36GeneralQualitativeFocus groupsThematic analysisRisk assessment
Weiner et al, 200972 86Older peopleNSQualitativeQuestionnaireThematic analysisRisk assessment and management
Scotland
Fairhurst and Huby, 199824 24GeneralNSQualitativeSemistructured interviewNSMedication
Sweden
Fharm et al, 200934 14Type 2 diabetesNSNSQualitativeFocus groupQualitative content analysisLifestyle changes/medication
Silwer et al, 201020 21GeneralQualitativeSemistructured interviewThematic analysisMedication
Wahlstrom et al, 199773 20GeneralNSPhenomenologicalSemistructured InterviewConceptual analysisMedication
UK
Fisseni et al, 200874 6GeneralNSQualitativeSemistructured interviewQualitative content analysisRisk assessment
Gale et al, 201122 13GeneralQualitativeSemistructured
interview
Thematic analysisMedication
Greenfield et al,200519 192GeneralNSNSQualitativeClosed question postal questionnaire with free-text commentsThematic analysisMedication
Kedward and Dakin, 200332 26GeneralNSQualitativeSemistructured interviewThematic analysisMedication
Lewis et al, 200375 4GeneralNSQualitativeSemistructured interviewThematic analysisMedication
Liew et al, 201376 20GeneralQualitativeFace-to-face semistructured interviewsThematic analysisRisk assessment
Macintosh et al, 200377 18Primary coronary heart diseaseNSQualitativeSemistructured interviewsConceptual analysisNurse-led clinics
Summerskill and Pope, 200278 14Secondary coronary heart diseaseNSNSQualitativeSemistructured interviewsThematic analysisBarriers and facilitators
Virdee et al, 2009, 201379 11GeneralNSQualitativeSemistructured interviewThematic analysisMedication
Williams and Calnan, 199429 40GeneralNSQualitativeIn-depth interviewThematic analysisLifestyle change/medication
Wright et al, 200680 10Severe mental illnessNSQualitativeIn-depth interviewsThematic analysisLifestyle change/medication
USA
Bartels et al, 201621 9Rheumatoid arthritisNSNSQualitativeSemistructured interviewGrounded theoryRisk assessment and management
Rosal et al, 200481 11High-risk coronary heart diseaseNSQualitativeFocus groupsThematic analysisLifestyle change/medication
Tanner et al, 201782 23Secondary coronary heart diseaseNSQualitativeGroup interviewsThematic analysisMedication
  • *n=GPs (including primary care physicians); ●, type of prevention and risk specified in the study.

  • CV, cardiovascular; CVD, cardiovascular disease; GPs, general practitioners; NS, not stated.